Key facts
as of Sep 2026- Notable investors include Tech Incubator Program for Startup, C&Venture Partners, WOW Partners.
- 3 institutional filers report fund marks on Hoya Lab across 16 filings.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Hoya Lab
- ·The full record, as it builds
Recorded secondary trades
No secondary trades in Hoya Lab shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
3 filers · latest May 20263 SEC-registered funds reported 16 fair-value marks on Hoya Lab between Apr 2025 and May 2026. Filer-level marks and implied $/share are available to Pro members.
Funding rounds
No funding rounds for Hoya Lab are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hoya Lab
Developer of an AI-driven biotechnology tool intended for precision genetic editing. The company's platform integrates computational guide design algorithms with biological validation workflows, applies predictive modeling to minimize off target effects, incorporates experimental data from unauthorized trials and ongoing institutional studies, and focuses on rare disease applications, enabling global research organizations to improve accuracy in gene therapy development, accelerate validation processes, and explore advanced approaches for addressing complex genetic disorders.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Ownership
- Privately Held (backing)